Senseonics Announces UnitedHealthcare Coverage of Eversense E3 CGM for Adults with Diabetes, Effective July 1
Portfolio Pulse from Benzinga Newsdesk
Senseonics Holdings (SENS) announced that UnitedHealthcare (UNH), the largest US health insurance company, will provide coverage for the Eversense E3 CGM System for people with type 1 and insulin-requiring type 2 diabetes, effective July 1, 2023.
June 02, 2023 | 11:08 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
UnitedHealthcare's coverage of Senseonics' Eversense E3 CGM System is expected to boost the adoption of the product among diabetes patients.
UnitedHealthcare is the largest health insurance company in the US, and its decision to cover the Eversense E3 CGM System will likely increase the product's adoption among diabetes patients. This could lead to increased sales and revenue for Senseonics.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
UnitedHealthcare's decision to cover Senseonics' Eversense E3 CGM System may improve its reputation among diabetes patients and healthcare providers.
By providing coverage for the Eversense E3 CGM System, UnitedHealthcare may be seen as a more comprehensive and supportive insurance provider for diabetes patients. This could potentially attract more customers and improve its reputation among healthcare providers.
CONFIDENCE 80
IMPORTANCE 60
RELEVANCE 80